1Gawchik SM,Saccar CL.Role of antileukotriene agents in asthma therapy[J].J Am Osteopath Assoc,2000,100(1):37-43.
2Turner CR,Breslow R,Conklyn MJ,et al.In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma[J].J Clin Invest,1996,97 (2):381-387.
3G Enrico Rovati,Michele Baroffio,Simona Citro,et al.Cysteinyl-leukotrienes in the regulation of β2-adrenoceptor function:an in vitro model of asthma[J].Respiratory Research,2006,7:103.
4Back M.Functionalc haracteristics of cysteinyl-leukotriene receptor subtypes[J].Life SCI,2002,71(5):611-622.
5Cohen P,Noveral JP,Bhala A,et al.Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis[J].Am J Physiol,1995,269(2P t1):L151-157.
6Wood-Baker R,Town GI,Benning B,et al.The reproducibility and efect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects[J].Br J Clin Phannacol,1995,39:119-123.
8Pefers SP.Leukotriene receptor antagonist in asthma therapy[J].Allergy Clin Immunol,2003,111(Suppl):62-67.
9Bisgaard Hans for the Study Group on Montelukast and Respiratory Syncytial Virus.A Randomized Trial of Montelukastin Respiratory Syncytial Virus Prostbronchiolitis[J].Am J Res Crit Care Med,2003,167:379-383.
二级参考文献21
1Adcock IM, Lane SJ, Brown CR, et al. Abnormal glucocorticold receptor-activator protein 1 interaction in steroid-resistant asthma[J]. J Exp Med, 1995,182(6): 1951-1958.
3Leung DY, Szefler SJ. New insights into steroid resistant asthma [J]. Pediatr Allergy Immunol, 1998,9(1):3-12.
4Leung DY, Martin RJ, Szefler SJ. Dysregulation of interleukin-4, interleukin-5, and interferon-gamma gene expression in steroid resistant asthma[J]. J Exp Med,1995,181(1) : 33-40.
5Sun Y, Luo W, Zhao R, et al. Steroid-resistant asthma:effects of glucocorticoids on interleukin-4 and interleukin-5 gene expression [J]. Chin Med J (Engl), 1998 , 111 (9):775-778.
6Devillier PH , Bessard G, Advancer CH. Les antagonists des leucotrienes: une approache nouvelle du treatment de 1' asthma [J]. Rev Malad Respir, 1997,14:159-170.
7Leff JA, Busse WW, PeDlman D, et al. Montelukast, a leukotriene-receptor antagonist for the mild asthma and exerciseinduced brocho-constriction[J]. N Engl J Med , 1998, 339(3) : 147.
8Lofdahl CG, Reiss TF, Leff JA, et al. Randomised,placebo controlled trial of effect of a leukotriene receptor antagonist,montelukast, on tapering inhaled corticosteroid in asthmatic patients[J]. BMJ, 1999, 19(7202): 87-90.
9Adcock IM, Ito K. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue[J]. Curr Opin Pharmacol,2004,4(3) : 257-262.
10Bateman ED, Boushey HA, Bousquet J, et al. Pauwels RA and Pedersen SE for the GOAL Investigators Group. Canguideline-defined asthma control be achieved the gaining optimal asthma control study[J]. Am J Resp Crir Care Med,2004, 170: 836-844.
